HIV Drug Resistance
The World Health Organization and its partners have developed a Global strategy for prevention and assessment of HIV drug resistance. The strategy measures the extent and risk of emergence of drug resistant HIV through the use of standardized minimum-resource assessments and surveys. The assessments provide evidence base to support optimal use of available antiretroviral drugs (ARVs), minimize site and programme factors associated with the emergence of HIV drug resistance, and thus optimize patient care. WHO/WPRO and its technical partners have provided technical assistance to five countries in the Western Pacific region, i.e., Cambodia, China, Malaysia, Papua New Guinea and Viet Nam, to adapt and implement their national HIV drug resistance strategies.